These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3561504)

  • 21. Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform.
    Poulet H; Minke J; Pardo MC; Juillard V; Nordgren B; Audonnet JC
    Vaccine; 2007 Jul; 25(30):5606-12. PubMed ID: 17227690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NIH finds Argentine experiment did not break U.S. biotechnology rules.
    Crawford M
    Science; 1987 Jan; 235(4786):276. PubMed ID: 3798112
    [No Abstract]   [Full Text] [Related]  

  • 23. Poxviruses as vaccine vectors.
    Pastoret PP; Vanderplasschen A
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):343-55. PubMed ID: 12818621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic vaccines against cancer and infectious diseases. Great possibilities in the research--small clinical progress so far].
    Kiessling R; Ljungberg K; Von Gabain A
    Lakartidningen; 2008 Sep 3-9; 105(36):2402-4. PubMed ID: 18831450
    [No Abstract]   [Full Text] [Related]  

  • 25. Oral vaccination of dogs (Canis familiaris) with baits containing the recombinant rabies-canine adenovirus type-2 vaccine confers long-lasting immunity against rabies.
    Zhang S; Liu Y; Fooks AR; Zhang F; Hu R
    Vaccine; 2008 Jan; 26(3):345-50. PubMed ID: 18083277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA-based immunisation against rabies and rabies-related viruses: towards multivalent vaccines.
    Perrin P; Jacob Y; Desmézières E; Tordo N
    Dev Biol (Basel); 2000; 104():151-7. PubMed ID: 11713814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB).
    Knowles MK; Roberts D; Craig S; Sheen M; Nadin-Davis SA; Wandeler AI
    Vaccine; 2009 May; 27(20):2662-8. PubMed ID: 19428876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rabies eradication in Belgium by fox vaccination using vaccinia-rabies recombinant virus.
    Brochier B; Pastoret PP
    Onderstepoort J Vet Res; 1993 Dec; 60(4):469-75. PubMed ID: 7777338
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioregulation. Technical slip almost forgiven.
    Palca J; Beardsley T
    Nature; 1986 Oct 30-Nov 5; 323(6091):752. PubMed ID: 3774002
    [No Abstract]   [Full Text] [Related]  

  • 30. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
    Xiang ZQ; Yang Y; Wilson JM; Ertl HC
    Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)].
    Thimme R; Heim M; Baumert TF; Nassal M; Moradpour D
    Dtsch Med Wochenschr; 2014 Apr; 139(15):778-82. PubMed ID: 24691691
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and non-target species.
    Knowles MK; Nadin-Davis SA; Sheen M; Rosatte R; Mueller R; Beresford A
    Vaccine; 2009 Nov; 27(47):6619-26. PubMed ID: 19698811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fowlpox virus as a recombinant vaccine vector for use in mammals and poultry.
    Skinner MA; Laidlaw SM; Eldaghayes I; Kaiser P; Cottingham MG
    Expert Rev Vaccines; 2005 Feb; 4(1):63-76. PubMed ID: 15757474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Onset of protective immunity in chicks after vaccination with a recombinant herpesvirus of turkeys vaccine expressing Newcastle disease virus fusion and hemagglutinin-neuraminidase antigens.
    Heckert RA; Riva J; Cook S; McMillen J; Schwartz RD
    Avian Dis; 1996; 40(4):770-7. PubMed ID: 8980804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of rabies neutralizing antibody in hen's eggs using a part of the G protein expressed in Escherichia coli.
    Motoi Y; Sato K; Hatta H; Morimoto K; Inoue S; Yamada A
    Vaccine; 2005 Apr; 23(23):3026-32. PubMed ID: 15811649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insect cell-derived VP2 of infectious bursal disease virus confers protection against the disease in chickens.
    Pitcovski J; Di-Castro D; Shaaltiel Y; Azriel A; Gutter B; Yarkoni E; Michael A; Krispel S; Levi BZ
    Avian Dis; 1996; 40(4):753-61. PubMed ID: 8980802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine.
    Brodersen HP; Beckers B; Köhler H; Dahlmanns C; Kruska L; Larbig D
    Nephrol Dial Transplant; 1997 Dec; 12(12):2756-7. PubMed ID: 9430890
    [No Abstract]   [Full Text] [Related]  

  • 38. [Contemporary vaccinology--scientific and practical aspects].
    Piotrowska-Jastrzebska J; Mikołuć B; Motkowski R
    Pol Merkur Lekarski; 2002 Jun; 12(72):526-9. PubMed ID: 12362676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental immunization of cats with a recombinant rabies-canine adenovirus vaccine elicits a long-lasting neutralizing antibody response against rabies.
    Hu RL; Liu Y; Zhang SF; Zhang F; Fooks AR
    Vaccine; 2007 Jul; 25(29):5301-7. PubMed ID: 17576027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of rabies DNA vaccine using a recombinant plasmid.
    Rai N; Kaushik P; Rai A
    Acta Virol; 2005; 49(3):207-10. PubMed ID: 16178518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.